Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Smartsheet: Q1 Earnings Insights

Smartsheet (NYSE:SMAR) reported its Q1 earnings results on Wednesday, June 7, 2023 at 04:05 PM. Here’s what investors…
byBenzinga Insights
June 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Smartsheet (NYSE:SMAR) reported its Q1 earnings results on Wednesday, June 7, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Smartsheet beat estimated earnings by 125.0%, reporting an EPS of $0.18 versus an estimate of $0.08.

Revenue was up $51.58 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 17.77% increase in the share price the next day.

Here’s a look at Smartsheet’s past performance:

Quarter Q4 2023 Q3 2023 Q2 2023 Q1 2023
EPS Estimate -0.01 -0.15 -0.2 -0.19
EPS Actual 0.07 -0.01 -0.1 -0.18
Revenue Estimate 206.17M 194.27M 180.23M 162.55M
Revenue Actual 212.34M 199.58M 186.69M 168.31M

To track all earnings releases for Smartsheet visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY

By Jelena Martinovic
April 2, 9:18 AM
Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company reported CA$16.8 million ($12.3 million) in total revenue, up by 314% year-over-year. Avicanna mostly attributed a surge in revenue to the acquisition of Medical Cannabis by Shoppers from Shoppers Drug Mart and the launch of MyMedi.ca. "2023 was a tremendous year for Avicanna where we solidified our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca," he said. "We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars."

AVCNF